Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 25
2024
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
804
+2.98%
|
-
|
|
Apr 25
2024
|
Monica P Reed Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+26.16%
|
-
|
|
Apr 25
2024
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+2.15%
|
-
|
|
Apr 23
2024
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,000
-7.32%
|
$740,000
$370.7 P/Share
|
|
Apr 23
2024
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.82%
|
$308,000
$154.24 P/Share
|
|
Apr 23
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,318
-89.89%
|
$1,967,660
$370.66 P/Share
|
|
Apr 23
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,318
+47.34%
|
$957,240
$180.41 P/Share
|
|
Mar 15
2024
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
5,041
-88.91%
|
$2,001,277
$397.07 P/Share
|
|
Mar 15
2024
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,224
+45.88%
|
$72,216
$59.23 P/Share
|
|
Mar 11
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
329
-1.95%
|
$128,310
$390.16 P/Share
|
|
Mar 11
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
329
+1.91%
|
$77,973
$237.92 P/Share
|
|
Mar 11
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-15.63%
|
$76,440
$390.16 P/Share
|
|
Mar 08
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
20,296
-14.54%
|
$7,976,328
$393.8 P/Share
|
|
Mar 08
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
14,728
+9.44%
|
$3,637,816
$247.37 P/Share
|
|
Mar 08
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-13.52%
|
$76,832
$392.02 P/Share
|
|
Mar 07
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-11.91%
|
$77,028
$393.3 P/Share
|
|
Mar 06
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-10.64%
|
$75,656
$386.76 P/Share
|
|
Mar 05
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-9.62%
|
$78,400
$400.0 P/Share
|
|
Mar 01
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,605
-84.34%
|
$614,715
$383.48 P/Share
|
|
Feb 29
2024
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,230
-9.91%
|
$1,246,780
$386.59 P/Share
|
|
Feb 29
2024
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,370
+16.23%
|
-
|
|
Feb 29
2024
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct |
987
-5.45%
|
$380,982
$386.59 P/Share
|
|
Feb 29
2024
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
2,006
+9.92%
|
-
|
|
Feb 29
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Payment of exercise price or tax liability
|
Direct |
935
-20.65%
|
$360,910
$386.59 P/Share
|
|
Feb 29
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
1,843
+28.82%
|
-
|
|
Feb 29
2024
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,428
-5.69%
|
$551,208
$386.59 P/Share
|
|
Feb 29
2024
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,817
+10.06%
|
-
|
|
Feb 29
2024
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,651
-1.65%
|
$637,286
$386.59 P/Share
|
|
Feb 29
2024
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
3,256
+3.13%
|
-
|
|
Feb 29
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
980
-2.06%
|
$378,280
$386.59 P/Share
|
|
Feb 29
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
2,201
+4.41%
|
-
|
|
Feb 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
1,700
-7.41%
|
$656,200
$386.59 P/Share
|
|
Feb 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
3,676
+13.74%
|
-
|
|
Feb 29
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,651
-38.31%
|
$637,286
$386.59 P/Share
|
|
Feb 29
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,256
+43.03%
|
-
|
|
Feb 29
2024
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,905
-0.44%
|
$735,330
$386.59 P/Share
|
|
Feb 29
2024
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,757
+0.85%
|
-
|
|
Feb 29
2024
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
470
-5.9%
|
$181,420
$386.59 P/Share
|
|
Feb 29
2024
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,317
+14.01%
|
-
|
|
Feb 28
2024
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
108,790
-27.06%
|
$41,884,150
$385.08 P/Share
|
|
Feb 28
2024
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
129,810
+23.62%
|
$19,341,690
$149.97 P/Share
|
|
Feb 27
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
843
-73.88%
|
$325,398
$386.46 P/Share
|
|
Feb 26
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
498
-5.19%
|
$193,722
$389.77 P/Share
|
|
Feb 26
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,587
+14.19%
|
-
|
|
Feb 26
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Payment of exercise price or tax liability
|
Direct |
434
-27.75%
|
$168,826
$389.77 P/Share
|
|
Feb 26
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
855
+35.35%
|
-
|
|
Feb 26
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
867
-43.18%
|
$337,263
$389.77 P/Share
|
|
Feb 26
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+45.99%
|
-
|
|
Feb 26
2024
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
649
-5.68%
|
$252,461
$389.77 P/Share
|
|
Feb 26
2024
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,650
+12.61%
|
-
|